EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias

Dates: April 25-26, 2025
Location: to be announced
Chairs: K Döhner, P Vyas, and MT Voso
Collaborating SWG: EHA Specialized Working Group on Acute Myeloid Leukemia

Registration will be open soon


The EHA-SWG scientific meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias will provide a thorough update on susceptibility factors to sAML, including germ-line and acquired molecular lesions, as well as the role of the bone marrow microenvironment. In addition, clinically important aspects such as sAML following childhood malignancies, leukemogenic effects of drugs as well as prevention/surveillance strategies will be discussed. Finally, the meeting will also focus on special situations including sAML following gene-therapy, CAR-T cell therapy, and AML of donor origin in the context of allogeneic stem cell transplantation.

Major experts in the molecular characterization of sAML and the translational consequences in disease diagnosis, management, and treatment will join the meeting and be part of an intensive scientific exchange. With this meeting, we would particularly encourage young researchers and clinician scientists to present their data on sAML in one of the abstract or poster sessions.

The meeting will cover the following topics:

  • Germ-line and acquired predisposition to sAML
  • Clonal progression from other myeloid diseases (BM-failure s., MDS, MPN)
  • Role of cancer treatment in t-AML development /after chemotherapy, CAR-T, gene therapy)
  • Genetic characteristics of sAML
  • Treatment of sAML
  • Allogeneic stem cell transplantation (donor-derived sAML), 7. prevention/surveillance programs

Target Audience

The meeting is intended for hematologists, oncologists, biomedical scientists, lab specialists/technicians, and patient advocates.


Registration will open soon.

Abstract & clinical case submission

Abstract & clinical case submission is an important part of this meeting. More details will be updated soon.


The meeting venue will be announced soon.


EBAH accredited stamp DEF2

Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.